Atropisomeric 8-arylchromen-4-ones exhibit enantioselective inhibition of the DNA-dependent protein kinase (DNA-PK)

被引:13
作者
Cano, Celine [1 ]
Golding, Bernard T. [1 ]
Haggerty, Karen [1 ]
Hardcastle, Ian R. [1 ]
Peacock, Marcus [2 ]
Griffin, Roger J. [1 ]
机构
[1] Univ Newcastle, No Inst Canc Res, Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] KuDOS Pharmaceut Ltd, Cambridge CB4 0PE, England
基金
英国工程与自然科学研究理事会;
关键词
DIRECTED ORTHO-METALATION; HUMAN TUMOR-CELLS; STRAND BREAK; POTENT; WORTMANNIN; RADIOSENSITIZATION; IDENTIFICATION; DISCOVERY; RADIATION; LY294002;
D O I
10.1039/b926245h
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Substitution at the 3-position of the dibenzothiophen-4-yl ring of 8-(dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-one NU7441, a potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor, with propyl, allyl or methyl enabled the separation by chiral HPLC of atropisomers. This is a consequence of restricted rotation about the dibenzothiophene-chromenone bond. Biological evaluation against DNA-PK of the pairs of atropisomers showed a marked difference in potency, with only one enantiomer being biologically active.
引用
收藏
页码:1922 / 1928
页数:7
相关论文
共 30 条
[1]   Judicious application of allyl protecting groups for the synthesis of 2-morpholin-4-yl-4-oxo-4H-chromen-8-yl triflate, a key precursor of DNA-dependent protein kinase inhibitors [J].
Aristegui, Sonsoles Rodriguez ;
El-Murr, Marine Desage ;
Golding, Bernard T. ;
Griffin, Roger J. ;
Hardcastle, Ian R. .
ORGANIC LETTERS, 2006, 8 (26) :5927-5929
[2]   Quinolinone and pyridopyrimidinone inhibitors of DNA-dependent protein kinase [J].
Barbeau, Olivier R. ;
Cano-Soumillac, Celine ;
Griffin, Roger J. ;
Hardcastle, Ian R. ;
Smith, Graeme C. M. ;
Richardson, Caroline ;
Clegg, William ;
Harrington, Ross W. ;
Golding, Bernard T. .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2007, 5 (16) :2670-2677
[3]   Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells [J].
Boulton, S ;
Kyle, S ;
Yalcintepe, L ;
Durkacz, BW .
CARCINOGENESIS, 1996, 17 (11) :2285-2290
[4]   Drug disposition in three dimensions: An update on stereoselectivity in pharmacokinetics [J].
Brocks, Dion R. .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2006, 27 (08) :387-406
[5]   Stereoselective binding of human serum albumin [J].
Chuang, VTG ;
Otagiri, M .
CHIRALITY, 2006, 18 (03) :159-166
[6]   The Challenge of Atropisomerism in Drug Discovery [J].
Clayden, Jonathan ;
Moran, Wesley J. ;
Edwards, Paul J. ;
LaPlante, Steven R. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (35) :6398-6401
[7]   Selective benzopyranone and pyrimido[2,1-α]isoquinolin-4-one inhibitors of DNA-dependent protein kinase:: Synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro [J].
Griffin, RJ ;
Fontana, G ;
Golding, BT ;
Guiard, S ;
Hardcastle, IR ;
Leahy, JJJ ;
Martin, N ;
Richardson, C ;
Rigoreau, L ;
Stockley, M ;
Smith, GCM .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) :569-585
[8]   Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion properties [J].
Guile, Simon D. ;
Bantick, John R. ;
Cooper, Martin E. ;
Donald, David K. ;
Eyssade, Christine ;
Ingall, Anthony H. ;
Lewis, Richard J. ;
Martin, Barrie P. ;
Mohammed, Rukhsana T. ;
Potter, Timothy J. ;
Reynolds, Rachel H. ;
St-Gallay, Stephen A. ;
Wright, Andrew D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (02) :254-263
[9]   Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach [J].
Hardcastle, IR ;
Cockcroft, X ;
Curtin, NJ ;
El-Murr, MD ;
Leahy, JJJ ;
Stockley, M ;
Golding, BT ;
Rigoreau, L ;
Richardson, C ;
Smith, GCM ;
Griffin, RJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) :7829-7846
[10]   Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase [J].
Hollick, Jonathan J. ;
Rigoreau, Laurent J. M. ;
Cano-Soumillac, Celine ;
Cockcroft, Xiaoling ;
Curtin, Nicola J. ;
Frigerio, Mark ;
Golding, Bernard T. ;
Guiard, Sophie ;
Hardcastle, Ian R. ;
Hickson, Ian ;
Hummersone, Marc G. ;
Menear, Keith A. ;
Martin, Niall M. B. ;
Matthews, Ian ;
Newell, David R. ;
Ord, Rachel ;
Richardson, Caroline J. ;
Smith, Graeme C. M. ;
Griffin, Roger J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (08) :1958-1972